Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Drug Name | BGB-B2033 |
Trade Name | |
Synonyms | BGB B2033|BGBB2033 |
Drug Descriptions |
Limited information is currently available on BGB-B2033, a putative bispecific antibody targeting TNFRSF9 (4-1BB) and GPC3 (Oct 2024). |
DrugClasses | GPC3 Antibody 5 TNFRSF9 Antibody 32 |
CAS Registry Number | NA |
NCIT ID | NA |
Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
---|---|---|---|
BGB-B2033 | BGB-B2033 | 0 | 1 |
BGB-B2033 + Tislelizumab | BGB-B2033 Tislelizumab | 0 | 1 |